Food Allergy and Anaphylaxis

The GameChangerA new study looks at the utility of omalizumab in preventing food allergy reactions after accidental exposure. ACEis and Beta-blockers should be avoided in patients with recurrent anaphylaxis if possible. HostGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint Health ReferenceStudy: https://www.nejm.org/doi/full/10.1056/NEJMoa2312382 Anaphylaxis guideline: https://www.annallergy.org/article/S1081-1206(23)01304-2/fulltext Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the OUtMATCH study results and their relevance to patients with food allergies.2. Interpret the new AAAAI anaphylaxis guidelines in relation to patient care.0.05 CEU/0.5 HrUAN: 0107-0000-24-079-H01-PInitial release date: 03/18/2024Expiration date: 03/18/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram